Fundraising FoxC4 Therapeutics
NASDAQ: CCCCUnicorn · $1.8BCambridge, US · Founded 2015 · Delaware corporation · 5 known investors
Find your way into C4 Therapeutics
Sign up to see every warm intro you have to C4 Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the C4 Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
C4 Therapeutics develops targeted protein degradation medicines aimed at treating disease. The company works in the biotechnology and drug development space.
Founders & leadership
C4 Therapeutics was founded in 2015 by Kenneth C. Anderson.
Board
Investors · 5
How we know: the VCSheet dataset · Not right? Tell us
How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us
How we know: Nextech Invest's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: RA Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the S-1 prospectus · a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcements$70.3M disclosed across 1 of 2 rounds · 2015–2020
- Undisclosed amountIPOOct 2020Source ↗
▶$70.3MraisedJan 2016 · 55 investors · BiotechnologyRule 506(b)
- Marc CohenExecutive Officer, Director
- Jason FishermanExecutive Officer, Director
- Miles StuchinDirector
- William M. ScalzulliDirector
- Kenneth AndersonDirector
- Malcolm S. SalterDirector
- Bruce DowneyDirector
- Jay EastmanDirector
- Alain CohenDirector
- Elena ProkupetsDirector
- Bihua ChenDirector
- Ronald W. KaiserDirector
- Offering amount
- $73.5M
- Amount sold
- $70.3M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 2
Companies working in the same space as C4 Therapeutics.
In the news
Frequently asked questions
- What does C4 Therapeutics do?
- C4 Therapeutics develops targeted protein degradation medicines aimed at treating disease. The company works in the biotechnology and drug development space.
- Who founded C4 Therapeutics?
- C4 Therapeutics was founded by Kenneth C. Anderson in 2015.
- Who are C4 Therapeutics's investors?
- C4 Therapeutics's investors include 3E Bioventures Capital, Bain Capital Life Sciences, Nextech Invest, RA Capital, Cobro Ventures.
- How much funding has C4 Therapeutics raised?
- C4 Therapeutics has disclosed $70.3M raised across 1 of its 2 known rounds.
- Where is C4 Therapeutics headquartered?
- C4 Therapeutics is headquartered in Cambridge, US.